Saadia Zahid

Dr. Saadia Zahid

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2017 in Neuroscience Bulletin
Verified
Journal Article
Closed access
PDF file
FMFatima Javed Mirza
Fatima Javed Mirza
SZSaadia Zahid
Saadia Zahid

1 March 2021 in Phytomedicine
Verified
Journal Article
Closed access
FMFatima Javed Mirza
Fatima Javed Mirza
SASanila Amber
Sanila Amber
SUSumera
Sumera
DHDeeba Hassan
Deeba Hassan
Touqeer AhmedTouqeer Ahmed
Touqeer Ahmed
SZSaadia Zahid
Saadia Zahid

24 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
SUSumera
Sumera
FAFarha Anwer
Farha Anwer
Maaz WaseemMaaz Waseem
Maaz Waseem
AFAreeba Fatima
Areeba Fatima
NMNishat Malik
Nishat Malik
SZSaadia Zahid
Saadia Zahid
Glioblastoma multiforme (GBM) is a tumor of glial origin and is the most malignant, aggressive and prevalent type, with the highest mortality rate in adult brain cancer. Surgical resection of the tumor followed by Temozolomide (TMZ) therapy is currently available, but the development of resistance to TMZ is a common limiting factor in effective treatment. The present study investigated the potential interactions of TMZ with several secretory proteins involved in various molecular and cellular processes in GBM. Automated docking studies were performed using AutoDock 4.2, which showed an encouraging binding affinity of TMZ towards all targeted proteins, with the strongest interaction and binding affinity with GDF1 and SLIT1, followed by NPTX1, CREG2 and SERPINI, among the selected proteins. Molecular dynamics (MD) simulations of protein–ligand complexes were performed via CABS-flex V2.0 and the iMOD server to evaluate the root-mean-square fluctuations (RMSFs) and measure protein stability, respectively. The results showed that docked models were more flexible and stable with TMZ, suggesting that it may be able to target putative proteins implicated in gliomagenesis that may impact radioresistance. However, additional in vitro and in vivo investigations can ascertain the potential of the selected proteins to serve as novel targets for TMZ for GBM treatment.

2 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
FMFatima Javed Mirza
Fatima Javed Mirza
SZSaadia Zahid
Saadia Zahid
R. M. Damian HolsingerR. M. Damian Holsinger
R. M. Damian Holsinger
Carnosic acid is a diterpenoid abundantly present in plants belonging to the genus Rosmarinus and Salvia of the family Lamiaceae, accounting for their application in traditional medicine. The diverse biological properties of carnosic acid that include antioxidant, anti-inflammatory, and anticarcinogenic activities have instigated studies on its mechanistic role, providing further insights into its potential as a therapeutic agent. Accumulating evidence has established the relevance of carnosic acid as a neuroprotective agent exhibiting therapeutic efficacy in combatting neuronal-injury-induced disorders. The physiological importance of carnosic acid in the mitigation of neurodegenerative disorders is just beginning to be understood. This review summarizes the current data on the mode of action through which carnosic acid exerts its neuroprotective role that may serve to strategize novel therapeutic approaches for these debilitating neurodegenerative disorders.

4 April 2017 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
SASara Ahmed
Sara Ahmed
ZMZahra Mahmood
Zahra Mahmood
AJAneela Javed
Aneela Javed
SHShoaib Naiyer Hashmi
Shoaib Naiyer Hashmi
IZInga Zerr
Inga Zerr
SZSaadia Zahid
Saadia Zahid

7 August 2015 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SASara Ahmed
Sara Ahmed
ZMZahra Mahmood
Zahra Mahmood
SZSaadia Zahid
Saadia Zahid